+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

A

Actively Recruiting

Healthy Volunteer

This research aims to better understand how epilepsy-related cognitive impairments affect driving ability. Epilepsy can impact attention and other cognitive functions important for safe driving, which is essential for maintaining independence and social integration. Current evaluations of driving fitness rely mainly on medical consultations, with unclear methods for comprehensive assessment. The study compares individuals with epilepsy who drive at least once a month to healthy volunteers matched by age, sex, and driving experience. It uses a driving simulator combined with EEG monitoring to assess various aspects of driving performance and cognitive function, including speed, attention, lane position, braking time, information processing, and visual scanning, all measured on the same day. Participants will undergo driving simulation and EEG evaluation to measure their driving-related cognitive skills. Researchers will analyze outcomes such as phasic alertness, sustained and divided attention, and reaction times. The study involves adults aged 18 to 65 who hold a category B driving license and actively drive, with no medical conditions preventing driving apart from epilepsy. The total study duration extends until November 2027.

Age: 18Years - 65YearsAll Genders
1 location
E

Actively Recruiting

Researchers are investigating whether adding canine mediation to psychomotor therapy can improve the quality of life for adults with epilepsy who have difficulty managing emotions, movement, or spatial awareness. This study explores the effects of interacting with a specially trained dog during therapy on patients anxiety, emotional control, self-esteem, cognition, and seizure frequency. The aim is to provide evidence on the benefits of animal-assisted therapy in this population, which currently lacks data on these effects. Participants are randomly assigned to one of two groups one receives weekly group psychomotor therapy sessions combined with canine mediation, and the other receives standard group psychomotor therapy sessions without animals. Both interventions take place once a week for 10 weeks. The canine mediation involves a trained dog and a certified canine educator working alongside a psychomotor therapist to engage participants in therapeutic activities that focus on emotions and commands. Throughout the study, participants quality of life is assessed at the start and one week after completing the 10 sessions. The study also monitors anxiety, emotional management, cognition, and seizure frequency. Participants must meet specific eligibility criteria, including having pharmacoresistant epilepsy and requiring psychomotor therapy. The study is sponsored by Fondation Ophtalmologique Adolphe de Rothschild and runs from September 2026 to March 2030.

Age: 18Years +All GendersPhase Not Applicable
2 locations
E

Actively Recruiting

Researchers are evaluating the impact of mindfulness on quality of life in patients with drug-resistant epilepsy, a condition often complicated by anxiety and depression. The study aims to assess if mindfulness can help patients better manage stress, self-acceptance, and emotional challenges related to their chronic condition. This non-drug approach is being compared to a psycho-educative program to find ways to improve well-being without medication side effects. The study has two phases. In the first phase, after a 2-month baseline period without intervention, participants are randomly assigned to either a mindfulness group or a psycho-educative group, each attending 12 weekly sessions over 3 months. Following this, both groups are monitored for 6 months. In the optional second phase, those originally in the psycho-educative group can join the mindfulness program and will be followed for an additional 6 months. Participants will attend regular assessment visits every 3 months and keep daily records of seizure frequency and emotional state. Researchers will evaluate quality of life using a specific questionnaire at 9 months and monitor changes in seizures, psychiatric symptoms, anxiety, stress, self-acceptance, and cognitive function. The study includes careful follow-up to understand how these interventions influence patients overall health and emotional well-being over time.

Age: 18Years +All GendersPhase Not Applicable
3 locations
N

Actively Recruiting

Epilepsy affects nearly 600,000 people in France and causes neurological seizures that may result in lasting impairments and stigma. People with epilepsy often engage in less physical activity than others due to barriers like fear of seizures during exercise, fatigue, and negative beliefs. This research aims to understand how anxiety, stigma, illness identity, and physical activity identity interact to influence physical activity among adults with epilepsy. Participants are asked to complete an online questionnaire assessing their physical activity levels. This questionnaire is completed twice, once at the start of the study and again six months later. The study observes these responses without administering any treatment or intervention. Throughout the study, participants provide information about their physical activity and related psychological factors. Researchers measure maintained physical activity between the start and six months after the initial questionnaire. The study runs from November 2025 to May 2027, during which participants are observed remotely through questionnaire responses.

All AgesAll Genders
1 location